Genital Diseases, Female  >>  Ovidrel (choriogonadotropin alfa)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ovidrel (choriogonadotropin alfa) / EMD Serono
NCT01851512: A Study to Evaluate the Tolerability, Safety and Pharmacokinetic Characteristics of DA-3803

Completed
1
27
RoW
T-R (Test-Reference drug), Drug: DA-3803 (Test drug), Drug: Ovidrel liquid injection (Referecne drug), R-T (Reference-Test drug)
Dong-A Pharmaceutical Co., Ltd.
Infertility, Induction of Ovulation
08/10
04/11

Download Options